JP Morgan Downgrades Aptiv to Neutral, Lowers Price Target to $56
JP Morgan analyst Rajat Gupta downgrades Aptiv (NYSE:APTV) from Overweight to Neutral and lowers the price target from $65 to $56.
Stocks · News reference
Dick's Sporting To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday
Analysts update ratings on top stocks. View all changes, including upgrades and downgrades, on analyst ratings page.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
StoneX Initiates Coverage On Aptiv with Buy Rating, Announces Price Target of $75
StoneX analyst Mickey Legg initiates coverage on Aptiv (NYSE:APTV) with a Buy rating and announces Price Target of $75.
Aptiv Director Agnevall Buys 4,100 Shares
Aptiv Director Hakan Agnevall purchased 4,100 shares at $48.58 per share on August 13, 2026, increasing his direct holdings by 30% to 17,797 shares. Despite the stock declining 33% over the past 12 months due to program delays and China market weakness, the insider purchase signals confidence in the company. Analysts remain bullish with 87% rating it as a buy and a median price target of $65.50, representing a 44% upside potential.
Why Is Chemours Stock Trading Higher Today?
Chemours PFAS settlement lifts shares as the $455 million deal clarifies liabilities, payment timing and future escrow obligations.
Chemours, DuPont De Nemours And Corteva Reach Settlement State Of North Carolina And 11 Local Entities; Overall Settlement Payments Total $455M Over 15 Years, With Chemours' 50% Share Of Payments Of ~$180M On NPV Basis Covered By Existing Accruals
The Chemours Company (NYSE:CC) (the "Company") today announced that, along with DuPont de Nemours, Inc. ("Dupont") and Corteva, Inc. ("Corteva"), it has entered into a settlement (the
8-K filing — Chemours Co (CC)
Filed: 2026-09-10 AccNo: 0001627223-26-000029 Size: 926 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits